Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective

por Purmonen, Timo, Puolakka, Kari, Bhattacharyya, Devarshi, Jain, Minal, Martikainen, Janne
Publicado en Cost Eff Resour Alloc (2018)